This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Jane E Harris: Innovator in Anticancer Agents
Introduction
Jane E Harris is a notable inventor based in Pennington, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. Her innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Jane E Harris holds a patent for "Substituted-triazolopyrimidines as anticancer agents." This invention provides a method for treating or inhibiting the growth of cancerous tumor cells and associated diseases in mammals. The method involves administering an effective amount of a substituted triazolopyrimidine derivative or a pharmaceutically acceptable salt thereof. Additionally, it promotes microtubule polymerization by interacting with tubulin and microtubules, further aiding in cancer treatment.
Career Highlights
Jane E Harris is currently associated with Wyeth, a prominent pharmaceutical company. Her work at Wyeth has allowed her to focus on innovative solutions in cancer therapy. With her expertise, she has contributed to advancements in the pharmaceutical industry.
Collaborations
Throughout her career, Jane has collaborated with notable colleagues, including Mark R Schmitt and Donald R Kirsch. These collaborations have fostered a productive environment for innovation and research in the field of cancer treatment.
Conclusion
Jane E Harris is a pioneering inventor whose work in anticancer agents showcases her commitment to improving healthcare. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire advancements in the pharmaceutical industry.